Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
CALL
IES Holdings
IESC
$15.1B
| $7.44M | ﹤0.01% |
37,000
+8,100
| +28% | +$1.95M |
|
3327
Aspen Aerogels
ASPN
$485M
| $7.42M | ﹤0.01% |
624,230
+226,445
| +57% | +$3.86M |
|
3328
PUT
iShares US Technology ETF
IYW
$25.6B
| $7.4M | ﹤0.01% |
46,400
+43,300
| +1,397% | +$6.85M |
|
3329
Hayward Holdings
HAYW
$3.22B
| $7.4M | ﹤0.01% |
483,841
-763,536
| -61% | -$12M |
|
3330
CALL
Camtek
CAMT
$7.72B
| $7.38M | ﹤0.01% |
91,400
-500
| -0.5% | -$39.3K |
|
3331
OSI Systems
OSIS
$3.76B
| $7.38M | ﹤0.01% |
44,069
-38,639
| -47% | -$6.13M |
|
3332
CALL
MP Materials
MP
$10.5B
| $7.38M | ﹤0.01% |
472,900
-397,400
| -46% | -$7.37M |
|
3333
PUT
Iovance Biotherapeutics
IOVA
$3.16B
| $7.38M | ﹤0.01% |
996,900
+340,200
| +52% | +$3.15M |
|
|
IAS
3334
DELISTED
Integral Ad Science
IAS
| $7.37M | ﹤0.01% |
706,343
-353,886
| -33% | -$3.88M |
|
3335
CALL
Noble Corp
NE
$7.2B
| $7.35M | ﹤0.01% |
234,201
+129,659
| +124% | +$4.29M |
|
3336
Riot Platforms
RIOT
$7.14B
| $7.35M | ﹤0.01% |
720,204
+225,285
| +46% | +$2.45M |
|
3337
Fortive
FTV
$18.6B
| $7.35M | ﹤0.01% |
130,006
-72,449
| -36% | -$4.16M |
|
3338
CALL
Ameriprise Financial
AMP
$50.3B
| $7.35M | ﹤0.01% |
13,800
-19,900
| -59% | -$10.6M |
|
3339
V2X
VVX
$2.6B
| $7.35M | ﹤0.01% |
153,576
+62,826
| +69% | +$3.73M |
|
3340
Enova International
ENVA
$6.61B
| $7.34M | ﹤0.01% |
76,566
-13,976
| -15% | -$1.33M |
|
3341
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
| $7.34M | ﹤0.01% |
76,700
-45,600
| -37% | -$4.49M |
|
3342
PUT
H&R Block
HRB
$6.83B
| $7.33M | ﹤0.01% |
138,800
-62,300
| -31% | -$3.66M |
|
3343
PUT
Asana
ASAN
$2.11B
| $7.32M | ﹤0.01% |
361,300
+142,900
| +65% | +$2.26M |
|
3344
PUT
KBR
KBR
$4.84B
| $7.32M | ﹤0.01% |
126,400
+25,800
| +26% | +$1.65M |
|
3345
PUT
Thor Industries
THO
$4.11B
| $7.32M | ﹤0.01% |
76,500
-350,200
| -82% | -$37.4M |
|
3346
CALL
iShares Russell Mid-Cap ETF
IWR
$58.4B
| $7.32M | ﹤0.01% |
82,800
+64,100
| +343% | +$5.82M |
|
3347
Vanguard Information Technology ETF
VGT
$150B
| $7.32M | ﹤0.01% |
94,144
-22,024
| -19% | -$1.69M |
|
3348
PUT
FirstEnergy
FE
$27.4B
| $7.31M | ﹤0.01% |
183,800
+48,200
| +36% | +$2.02M |
|
3349
CALL
Omega Healthcare
OHI
$14.1B
| $7.31M | ﹤0.01% |
193,100
-75,200
| -28% | -$3.01M |
|
3350
CALL
Rhythm Pharmaceuticals
RYTM
$7.95B
| $7.29M | ﹤0.01% |
130,300
+83,300
| +177% | +$4.6M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.